1. Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients. (March 2019) Authors: Rogado, J.; Sánchez-Torres, J.M.; Romero-Laorden, N.; Ballesteros, A.I.; Pacheco-Barcia, V.; Ramos-Leví, A.; Arranz, R.; Lorenzo, A.; Gullón, P.; Donnay, O.; Adrados, M.; Costas, P.; Aspa, J.; Alfranca, A.; Mondéjar, R.; Colomer, R. Journal: European journal of cancer Issue: Volume 109(2019) Page Start: 21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗